European Medicines Agency (EMA) | What's new Follow Orphan designation: infliximab Treatment of Kawasaki disease, 20/05/2026 Positive https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-26-3236 ema.europa.eu
